GAP 4 Movember - prostate cancer

Biography

I am a Senior Lecturer in Exercise Physiology and Programme Director for the Sport and Exercise Sciences degree at the University of Surrey. I have received my PhD from the University of Maastricht under the mentorship of Prof. Luc van Loon and Wim Saris focusing on the insulinotropic and anabolic properties of dietary protein in type 2 diabetes. After my PhD I have worked as a post-doctoral researcher at both the Faculties of Health, Medicine & Life Sciences at Maastricht University, the Netherlands (with Prof van Loon) and the Faculty of Kinesiology, KU Leuven, Belgium (with Prof. P Hespel) focussing on the beneficial health effects of exercise training and dietary modulation in type 2 diabetes and the elderly. I have spent time as a visiting researcher at Prof. Martin Gibala’s lab at MacMaster University, Canada studying the effect of different training modalities and nutritional interventions to optimise glycemic control. Next to my research activities I have been involved in the supervision of several amateur and professional athletes regarding performance and nutrition and currently I work with people living with and beyond cancer by using exercise to improve health and wellbeing.

See profile

Biography

Hardev Pandha is a clinician scientist and medical oncologist who graduated in medicine at the University of Birmingham. He trained in internal medicine and subsequently in medical oncology at the Royal Postgraduate Medical School at Hammersmith Hospital, London. He completed his PhD (Imperial College) in the Imperial Cancer Research Fund labs at the Hammersmith. He was a visiting fellow at Stanford University prior to completing his medical oncology training at the Royal Marsden Hospital, London. He was a senior lecturer in tumour immunology and medical oncology at St Georges, University of London in 2000 before being appointed Prof of Urological Oncology at the University of Surrey in 2006.

His areas of expertise include the management of patients with Urological cancers and malignant melanoma. He has a key interest in early phase clinical trials involving targeted agents and the translational aspects of novel therapies. His portfolio includes gene and viral therapy as well as immunotherapy and small molecule inhibitors. His laboratory interests reflect this and in particular a combination of novel and biological therapies with more conventional treatments. His lab team have evolved a robust infrastructure of patient sample procurement and biobanking for translational research.

See profile

Biography

Victoria Revell is an Associate Professor in Translational Sleep and Circadian Physiology, with over 20 years of experience in conducting human sleep and circadian research, both basic clinical research and clinical trials.  She has published over 50 original research and review articles in this area.

See profile